Tedford CE - Search Results

1

Development of a sensitive and quantitative analytical method for 1H-4-substituted imidazole histamine H3-receptor antagonists utilizing high-performance liquid chromatography and dabsyl derivatization.

Handley MK, Hirth WW, Phillips JG, Ali SM, Khan A, Fadnis L, Tedford CE. Handley MK, et al. Among authors: tedford ce. J Chromatogr B Biomed Sci Appl. 1998 Sep 25;716(1-2):239-49. doi: 10.1016/s0378-4347(98)00272-2. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9824237

2

High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.

Tedford CE, Hoffmann M, Seyedi N, Maruyama R, Levi R, Yates SL, Ali SM, Phillips JG. Tedford CE, et al. Eur J Pharmacol. 1998 Jun 26;351(3):307-11. doi: 10.1016/s0014-2999(98)00396-3. Eur J Pharmacol. 1998. PMID: 9721022 Free article.

3

New acetylene based histamine H3 receptor antagonists derived from the marine natural product verongamine.

Ali SM, Tedford CE, Gregory R, Yates SL, Phillips JG. Ali SM, et al. Among authors: tedford ce. Bioorg Med Chem Lett. 1998 May 19;8(10):1133-8. doi: 10.1016/s0960-894x(98)00181-4. Bioorg Med Chem Lett. 1998. PMID: 9871722

4

Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.

Ali SM, Tedford CE, Gregory R, Handley MK, Yates SL, Hirth WW, Phillips JG. Ali SM, et al. Among authors: tedford ce. J Med Chem. 1999 Mar 11;42(5):903-9. doi: 10.1021/jm980310g. J Med Chem. 1999. PMID: 10072687

5

Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.

Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE. Yates SL, et al. Among authors: tedford ce. J Pharmacol Exp Ther. 1999 May;289(2):1151-9. J Pharmacol Exp Ther. 1999. PMID: 10215699

6

Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.

Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Handley MK, Yates SL. Tedford CE, et al. J Pharmacol Exp Ther. 1999 May;289(2):1160-8. J Pharmacol Exp Ther. 1999. PMID: 10215700

7

Effects of selected histamine H3 receptor antagonists on tele-methylhistamine levels in rat cerebral cortex.

Yates SL, Tedford CE, Gregory R, Pawlowski GP, Handley MK, Boyd DL, Hough LB. Yates SL, et al. Among authors: tedford ce. Biochem Pharmacol. 1999 May 1;57(9):1059-66. doi: 10.1016/s0006-2952(98)00378-5. Biochem Pharmacol. 1999. PMID: 10796076

8

Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.

Tedford CE, Yates SL, Pawlowski GP, Nalwalk JW, Hough LB, Khan MA, Phillips JG, Durant GJ, Frederickson RC. Tedford CE, et al. J Pharmacol Exp Ther. 1995 Nov;275(2):598-604. J Pharmacol Exp Ther. 1995. PMID: 7473144

9

Therapeutic potential of histamine H3 receptor agonists and antagonists.

Leurs R, Blandina P, Tedford C, Timmerman H. Leurs R, et al. Trends Pharmacol Sci. 1998 May;19(5):177-83. doi: 10.1016/s0165-6147(98)01201-2. Trends Pharmacol Sci. 1998. PMID: 9652190 Review.

10

Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.

Tedford CE, Crosby G Jr, Iorio LC, Chipkin RE. Tedford CE, et al. Eur J Pharmacol. 1992 Feb 11;211(2):169-76. doi: 10.1016/0014-2999(92)90525-9. Eur J Pharmacol. 1992. PMID: 1535318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters